Title of article
Alefacept in the treatment of psoriasis
Author/Authors
Hideaki Sugiyama، نويسنده , , Thomas S. McCormick، نويسنده , , Kevin D. Cooper، نويسنده , , Neil J. Korman، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
6
From page
503
To page
508
Abstract
Alefacept is the first biologic agent approved by the US Food and Drug Administration for the treatment of psoriasis. To date, more than 1000 patients with moderate to severe psoriasis have been enrolled in phase III clinical trials of alefacept. More tha
Journal title
Clinics in Dermatology
Serial Year
2008
Journal title
Clinics in Dermatology
Record number
583249
Link To Document